China NMPA Product Recall - Implantable cardioverter defibrillator

On March 9, 2020, the National Medical Products Administration (NMPA) announced a voluntary recall initiated by St. Jude Medical Coordination Center BVBA (Belgium). This recall addresses certain batches of implantable cardiac defibrillators, as reported by Abbott Medical Products (Shanghai) Co., Ltd. The critical issue identified is a potential loss of radio frequency (RF) communication within these devices. This malfunction can lead to significant interruptions in remote monitoring and data transmission, which are vital for patient safety and device management. The regulatory framework for this action is overseen by the NMPA in China, with St. Jude Medical Coordination Center BVBA undertaking the recall voluntarily to address the product deficiency. Specific details regarding the models, specifications, and batch numbers of the affected products are provided in an accompanying "Medical Device Recall Event Report Form" referenced in the official notice. This proactive measure underscores the importance of reliable communication capabilities in high-risk medical devices to ensure continuous patient care and effective oversight.